Berdel We

Anti-tumor action of alkyl-lysophospholipids (Review).

Berdel We, Bausert Wr, U. Fink et al. · PubMed · 1981 · 80 citations

Medicine, Oncology, Pharmacology +16

Early assessment of minimal residual disease in AML by flow cytometry during aplasia identifies patients at increased risk of relapse

Thomas Köhnke, Diane Sauter, Katharina Ringel et al. · Leukemia · 2014 · 67 citations

Medicine, Hematology, Pathology +15

Inhibition by alkyl-lysophospholipids of tritiated thymidine uptake in cells of human malignant urologic tumors.

Berdel We, U. Fink, Boris Egger et al. · PubMed · 1981 · 46 citations

Medicine, Oncology, Pharmacology +10

Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro.

Berdel We, R. Korth, Andreas S. Reichert et al. · PubMed · 1988 · 28 citations

Medicine, Oncology, Pharmacology +10

Growth inhibition of malignant hypernephroma cells by autologous lysophospholipid incubated macrophages obtained by a new method.

Berdel We, U. Fink, Boris Egger et al. · PubMed · 1981 · 14 citations

Life Sciences, Cell Biology, Immunology +13